Pain

  • The role of ISCHEMIA in stable ischemic heart disease
    Nikolaos Spilias, MD, Benjamin Zorach, MD, Kara Denby, MD and Stephen Ellis, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 401-409; DOI: https://doi.org/10.3949/ccjm.87a.20033

    Decisions regarding treatment of stable ischemic heart disease must remain individualized.

  • Stable coronary artery disease: Intervene or not?
    Vinayak Nagaraja, MBBS, MS, MMed (Clin Epi), FRACP and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 410-415; DOI: https://doi.org/10.3949/ccjm.87a.20048

    Stable coronary artery disease needs a patient-centered approach, and one size does not fit all.

  • Vertebral fractures after denosumab cessation
    Jolan Dupont, MD, Michaël R. Laurent, MD,PhD, Lenore Dedeyne, MSc, Frank P. Luyten, MD,PhD, Evelien Gielen, MD,PhD and Marian Dejaeger, MD,PhD
    Cleveland Clinic Journal of Medicine June 2020, 87 (6) 337-338; DOI: https://doi.org/10.3949/ccjm.87a.19152

    The patient had a 6-month history of lumbar and dorsal back pain, initially suspected to be facet arthrosis.

  • Denosumab cessation
    Chad L. Deal, MD
    Cleveland Clinic Journal of Medicine June 2020, 87 (6) 339-341; DOI: https://doi.org/10.3949/ccjm.87a.20040

    Bone loss is rapid if patients miss injections. Clinicians can take extra measures to ensure patients get appropriate treatment.